VC

Vaman Chandrayan Rao

Active Director Director DIN 09335005
DIN 09335005 First appointment Oct 2021 Primary industry Recycling & Waste Management
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Vaman Chandrayan Rao

Data last updated:

Vaman Chandrayan Rao is a Director at Nesara Biotech Private Limited (since 2021). The company operates in Recycling & Waste Management.

DIN 09335005
Primary Designation Director
Industry Recycling & Waste Management
First Appointment 01 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nesara Biotech Private Limited U37200KA2021PTC146705
Director01 Oct 20212021Active

Directorship timeline

Open interactive timeline →
Nesara Biotech Private Limited
Premium access

Shareholding and investment profile for Vaman Chandrayan Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaman Chandrayan Rao

Vaman Chandrayan Rao currently holds 1 directorship: Nesara Biotech Private Limited (Director, since 01 Oct 2021).

Vaman Chandrayan Rao was first appointed on 01 Oct 2021 as Director at Nesara Biotech Private Limited.

The current boards of Vaman Chandrayan Rao's companies include Gulzar (Nesara Biotech Private Limited), Ramakrishna Baddankodi (Nesara Biotech Private Limited), Shimoga Muddappa Vidya (Nesara Biotech Private Limited), Sreenivasalu Honnali Anil Kumar (Nesara Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available